file,ref_number,ref_text,doi,doi_url,titleDoi,firstAuthDoi,author_similarity,title_similarity
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MUC16_MGMT_medium_methylated,[1],"Li J, Yen C, Liaw D, et al. 1997. Science. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.",10.1126/science.275.5308.1943,https://doi.org/10.1126/science.275.5308.1943,"<i>PTEN</i>
            , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer",Li,100,99
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MUC16_MGMT_medium_methylated,[2],"Gubbels JA, Belisle J, Onda M, et al. 2006. Cancer Res. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.",10.1186/1476-4598-5-50,https://doi.org/10.1186/1476-4598-5-50,"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors",Gubbels,100,100
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MUC16_MGMT_medium_methylated,[3],"Hegi ME, Diserens AC, Gorlia T, et al. 2005. N Engl J Med. MGMT gene silencing and benefit from temozolomide in glioblastoma.",10.1056/nejmoa043331,https://doi.org/10.1056/nejmoa043331,<i>MGMT</i>Gene Silencing and Benefit from Temozolomide in Glioblastoma,Hegi,100,98
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MUC16_MGMT_medium_methylated,[4],"Stupp R, Mason WP, van den Bent MJ, et al. 2005. N Engl J Med. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.",10.1097/01.cot.0000289242.47980.f9,https://doi.org/10.1097/01.cot.0000289242.47980.f9,“Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma”,Stupp,100,100
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MUC16_MGMT_medium_methylated,[5],"Weller M, van den Bent M, Tonn JC, et al. 2017. Lancet Oncol. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.",10.1016/s1470-2045(17)30194-8,https://doi.org/10.1016/s1470-2045(17)30194-8,European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas,Weller,100,100
